Chemoprevention in African American Men with Prostate Cancer

Author:

Kumar Nagi B.123,Pow-Sang Julio M.12,Spiess Philippe E.234,Park Jong Y.3567,Chornokur Ganna13,Leone Andrew R.4,Phelan Catherine M.13

Affiliation:

1. Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida

2. Genitourinary Oncology Programs, H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida

3. Departments of Oncologic Sciences, University of South Florida, Tampa, Florida

4. Urology, University of South Florida, Tampa, Florida

5. Molecular Medicine, University of South Florida, Tampa, Florida

6. Cell, Molecular and Microbiology, University of South Florida, Tampa, Florida

7. Epidemiology and Biostatistics, University of South Florida, Tampa, Florida.

Abstract

Background Recommendations for cancer screening are uncertain for the early detection or prevention of prostate cancer in African American men. Thus, chemoprevention strategies are needed to specifically target African American men. Methods The evidence was examined on the biological etiology of disparities in African Americans related to prostate cancer. Possible chemopreventive agents and biomarkers critical to prostate cancer in African American men were also studied. Results High-grade prostatic intraepithelial neoplasia may be more prevalent in African American men, even after controlling for age, prostate-specific antigen (PSA) level, abnormal results on digital rectal examination, and prostate volume. Prostate cancer in African American men can lead to the overexpression of signaling receptors that may mediate increased proliferation, angiogenesis, and decreased apoptosis. Use of chemopreventive agents may be useful for select populations of men. Conclusions Green tea catechins are able to target multiple pathways to address the underlying biology of prostate carcinogenesis in African American men, so they may be ideal as a chemoprevention agent in these men diagnosed with high-grade prostatic intraepithelial neoplasia.

Publisher

SAGE Publications

Subject

Oncology,Hematology,General Medicine

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3